138 related articles for article (PubMed ID: 19118898)
21. Silencing of secreted frizzled-related protein genes in MSI colorectal carcinogenesis.
Tanaka J; Watanabe T; Kanazawa T; Tada T; Kazama Y; Tanaka T; Nagawa H
Hepatogastroenterology; 2008; 55(85):1265-8. PubMed ID: 18795670
[TBL] [Abstract][Full Text] [Related]
22. Blockade of Wnt signaling inhibits angiogenesis and tumor growth in hepatocellular carcinoma.
Hu J; Dong A; Fernandez-Ruiz V; Shan J; Kawa M; Martínez-Ansó E; Prieto J; Qian C
Cancer Res; 2009 Sep; 69(17):6951-9. PubMed ID: 19690140
[TBL] [Abstract][Full Text] [Related]
23. Hypermethylation of Wnt antagonist gene promoters and activation of Wnt pathway in myelodysplastic marrow cells.
Masala E; Valencia A; Buchi F; Nosi D; Spinelli E; Gozzini A; Sassolini F; Sanna A; Zecchi S; Bosi A; Santini V
Leuk Res; 2012 Oct; 36(10):1290-5. PubMed ID: 22742816
[TBL] [Abstract][Full Text] [Related]
24. sFRP1 Expression Regulates Wnt Signaling in Chronic Myeloid Leukemia K562 Cells.
Pehlivan M; Caliskan C; Yuce Z; Sercan HO
Anticancer Agents Med Chem; 2022; 22(7):1354-1362. PubMed ID: 34030621
[TBL] [Abstract][Full Text] [Related]
25. The Wnt antagonists DKK1 and SFRP1 are downregulated by promoter hypermethylation in systemic sclerosis.
Dees C; Schlottmann I; Funke R; Distler A; Palumbo-Zerr K; Zerr P; Lin NY; Beyer C; Distler O; Schett G; Distler JH
Ann Rheum Dis; 2014 Jun; 73(6):1232-9. PubMed ID: 23698475
[TBL] [Abstract][Full Text] [Related]
26. Triptolide inhibits Bcr-Abl transcription and induces apoptosis in STI571-resistant chronic myelogenous leukemia cells harboring T315I mutation.
Shi X; Jin Y; Cheng C; Zhang H; Zou W; Zheng Q; Lu Z; Chen Q; Lai Y; Pan J
Clin Cancer Res; 2009 Mar; 15(5):1686-97. PubMed ID: 19240172
[TBL] [Abstract][Full Text] [Related]
27. CpG island methylation and expression of the secreted frizzled-related protein gene family in chronic lymphocytic leukemia.
Liu TH; Raval A; Chen SS; Matkovic JJ; Byrd JC; Plass C
Cancer Res; 2006 Jan; 66(2):653-8. PubMed ID: 16423993
[TBL] [Abstract][Full Text] [Related]
28. [Methylation status of id4 gene promoter in patients with chronic myeloid leukemia].
Wang XR; Kang HY; Cen J; Li YH; Wang LL; Yu L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Dec; 18(6):1402-4. PubMed ID: 21176338
[TBL] [Abstract][Full Text] [Related]
29. Functional significance of secreted Frizzled-related protein 1 in metastatic renal cell carcinomas.
Saini S; Liu J; Yamamura S; Majid S; Kawakami K; Hirata H; Dahiya R
Cancer Res; 2009 Sep; 69(17):6815-22. PubMed ID: 19723665
[TBL] [Abstract][Full Text] [Related]
30. Preferential hypermethylation of the Dickkopf-1 promoter in core-binding factor leukaemia.
Suzuki R; Onizuka M; Kojima M; Shimada M; Fukagawa S; Tsuboi K; Kobayashi H; Shintani A; Ogawa Y; Kawada H; Hotta T; Ando K
Br J Haematol; 2007 Sep; 138(5):624-31. PubMed ID: 17686056
[TBL] [Abstract][Full Text] [Related]
31. [Study of calcitonin gene methylation in chronic myeloid leukemia by using Hpa II-PCR].
Tan B; Cao P; Qi Z
Hunan Yi Ke Da Xue Xue Bao; 1999; 24(4):371-3. PubMed ID: 12080652
[TBL] [Abstract][Full Text] [Related]
32. Novel complex t(V;9;22) rearrangements in three cases with chronic myeloid leukemia and a rare translocation in a case with classical Philadelphia chromosome.
Mkrtchyan H; Ghazaryan S; Avetisyan G; Hovhannisyan A; Muradyan L; Daghbashyan S; Karst C; Gross M; Hinreiner S; Aroutiounian R; Liehr T
Oncol Rep; 2008 Jul; 20(1):99-104. PubMed ID: 18575724
[TBL] [Abstract][Full Text] [Related]
33. Epigenetic silencing of sFRP1 activates the canonical Wnt pathway and contributes to increased cell growth and proliferation in hepatocellular carcinoma.
Kaur P; Mani S; Cros MP; Scoazec JY; Chemin I; Hainaut P; Herceg Z
Tumour Biol; 2012 Apr; 33(2):325-36. PubMed ID: 22351518
[TBL] [Abstract][Full Text] [Related]
34. The SFRP family of WNT inhibitors function as novel tumor suppressor genes epigenetically silenced in medulloblastoma.
Kongkham PN; Northcott PA; Croul SE; Smith CA; Taylor MD; Rutka JT
Oncogene; 2010 May; 29(20):3017-24. PubMed ID: 20208569
[TBL] [Abstract][Full Text] [Related]
35. Chronic myelogenous leukemia with the e6a2 BCR-ABL and lacking imatinib response: presentation of two cases.
Vefring HK; Gruber FX; Wee L; Hovland R; Hjorth-Hansen H; Gedde Dahl T; Meyer P
Acta Haematol; 2009; 122(1):11-6. PubMed ID: 19641300
[TBL] [Abstract][Full Text] [Related]
36. Sfrp1, Sfrp2, and Sfrp5 regulate the Wnt/beta-catenin and the planar cell polarity pathways during early trunk formation in mouse.
Satoh W; Matsuyama M; Takemura H; Aizawa S; Shimono A
Genesis; 2008 Feb; 46(2):92-103. PubMed ID: 18257070
[TBL] [Abstract][Full Text] [Related]
37. Expression profile of WNT, FZD and sFRP genes in human hematopoietic cells.
Sercan Z; Pehlivan M; Sercan HO
Leuk Res; 2010 Jul; 34(7):946-9. PubMed ID: 20206998
[TBL] [Abstract][Full Text] [Related]
38. Methylation-associated silencing of SFRP1 with an 8p11-12 amplification inhibits canonical and non-canonical WNT pathways in breast cancers.
Yang ZQ; Liu G; Bollig-Fischer A; Haddad R; Tarca AL; Ethier SP
Int J Cancer; 2009 Oct; 125(7):1613-21. PubMed ID: 19569235
[TBL] [Abstract][Full Text] [Related]
39. Methylation-associated silencing of SFRP1 gene in high-grade serous ovarian carcinomas.
Kardum V; Karin V; Glibo M; Skrtic A; Martic TN; Ibisevic N; Skenderi F; Vranic S; Serman L
Ann Diagn Pathol; 2017 Dec; 31():45-49. PubMed ID: 29146058
[TBL] [Abstract][Full Text] [Related]
40. Imatinib mesylate efficacy in 72 previously treated Philadelphia-positive chronic myeloid leukemia patients with and without additional chromosomal changes: single-center results.
Holzerová M; Faber E; Veselovská J; Urbánková H; Balcárková J; Rozmanová S; Voglová J; Muzík J; Chroust K; Indrák K; Jarosová M;
Cancer Genet Cytogenet; 2009 May; 191(1):1-9. PubMed ID: 19389502
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]